In this study, we demonstrate how the amount of both membrane-anchored and soluble fractalkine depends on GSK-3β activity/levels, a kinase which has been proposed as a key element in AD pathology [29] and with many other implications in other neurological disorders as well [28]. The gene discussed is GSK3B; the disease is nervous system disorder.